Showing results (231-240 of 260) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2021
FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 MutationE Dianne Pulte, Kelly J Norsworthy, Yaping Wang, et al.
Archives of Oral Biology|March 23, 2013
Osteoarthritis in temporomandibular joint of Col2a1 mutant miceM L Ricks, J T Farrell, D J Falk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid LeukemiaKelly J Norsworthy, Kunthel By, Sriram Subramaniam, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 7, 2023
Feasibility of an online consensus approach for the diagnosis of cognitive impairment and dementia in rural South AfricaDarina T Bassil, Meagan T Farrell, Albert Weerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2019
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 MutationKelly J Norsworthy, Lola Luo, Vicky Hsu, et al.
Global Advances in Integrative Medicine and Health|September 2, 2025
Acupuncture Treatment for Individuals With Myasthenia Gravis - A Pilot Randomized Clinical TrialAmanda A Herrmann, Ella A Chrenka, Lap Pui Chung, et al.
JCI Insight|November 21, 2023
Lactate- and immunomagnetic-purified hiPSC-derived cardiomyocytes generate comparable engineered cardiac tissue constructsKalina J Rossler, Willem J de Lange, Morgan W Mann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2020
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic AnalysisKelly J Norsworthy, Flora Mulkey, Emma C Scott, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Lactate and Immunomagnetic-purified iPSC-derived Cardiomyocytes Generate Comparable Engineered Cardiac Tissue ConstructsKalina J Rossler, Willem J de Lange, Morgan W Mann, et al.
The Oncologist|December 7, 2013
U.S. Food and Drug Administration approval summary: omacetaxine mepesuccinate as treatment for chronic myeloid leukemiaFiroozeh Alvandi, Virginia E Kwitkowski, Chia-Wen Ko, et al.
Pageof 26